Today, patients, physicians, nurse coordinators and family members gather with purpose, focus and appreciation to celebrate survivorship and compassionate care.
Throughout our history the lymphoma and transplant programs at the University of Nebraska Medical Center have experienced much success and growth. Today the programs are recognized as world leaders in treating patients with lymphoma and in transplantation.
Each day UNMC’s teams of experts remain steadfast in their mission and continue to develop new methods of diagnosis, therapy and prevention.
Your charitable gifts, whether made today or in the future, are an investment in our commitment to help alleviate the devastation caused by blood cancer.
This fund supports cutting-edge research in the areas of non-Hodgkin’s lymphoma, Hodgkin’s disease, acute and chronic leukemias, myelodysplastic syndromes and multiple myeloma, among other related diseases.
This fund supports the collaborative work of the researchers in order to facilitate a more rapid translation of research discoveries to benefit cancer patients.
This fund is dedicated to the physicians, nurses and scientists who are
diligently working toward new, more effective cancer treatments,
diagnoses and ultimately a cure.
Research is crucial to the advancement in transplant and other cancer treatments. It is through research we look for better, more effective ways to kill cancer cells. This fund supports research in advanced hematopoietic stem cell transplantation and the treatment of transplantation side effects such as graft-versus-host disease.
Senior Director of Development
800-432-3216 toll free
© 2013 University of Nebraska Foundation - Site Credits